New study: could a wearable heart monitor after fainting save lives?
NCT ID NCT05066347
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether using a portable heart monitor for 15 days after a fainting episode can detect dangerous heart rhythms that standard short-term monitoring might miss. About 580 adults who fainted and are at medium or high risk will be randomly assigned to either usual care or wearing the Cardiophone Plus device at home. The goal is to see if longer monitoring leads to better detection and treatment of heart rhythm problems, improving patient safety.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Cardiophone Plus (portable heart monitor)
What this could lead to
If successful, this could show that longer home monitoring after fainting helps catch hidden heart rhythm problems early, potentially preventing serious events.
What could go wrong
This is a relatively small, early-stage trial focused on detection, not treatment. The device may not catch all dangerous rhythms, and false alarms could cause unnecessary worry or tests.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYNCOPE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Ottawa Hospital - Civic and General Campuses
RECRUITINGOttawa, Ontario, K1Y 4E9, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact